Werneburg Glenn T, Hettel Daniel, Jeong Stacy, Nemunaitis Gregory, Taliercio Jonathan J, Wood Hadley M
Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Department of Physical Medicine and Rehabilitation, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
J Urol. 2023 Feb;209(2):391-398. doi: 10.1097/JU.0000000000003070. Epub 2022 Nov 16.
Individuals with neuromuscular disorders and neurogenic lower urinary tract dysfunction are commonly nonweight-bearing with lower lean muscle mass than the general population. We sought to compare estimated glomerular filtration rate equations that include creatinine, cystatin C, or both, in nonweight-bearing individuals and matched ambulatory controls.
Records were reviewed for individuals with serum creatinine (Cr) and cystatin C (Cys) and diagnosis consistent with nonweight-bearing status, and matched ambulatory controls. The 2021 CKD-EPI (Chronic Kidney Disease-Epidemiology Collaboration) race agnostic equations were used to calculate estimated glomerular filtration rate. Renal function was compared by equation in the overall cohorts and in a patient subset with imaging and/or urinalysis evidence of renal dysfunction.
Nonweight-bearing (n = 102) and control populations (n = 204) had similar demographics. In the nonweight-bearing population, estimated glomerular filtration rate differed when calculated using CKD-EPI, CKD-EPI and CKD-EPI (107, 93, 80 mL/min/1.73 m, respectively, < .001). The differences in estimated glomerular filtration rate were greater in the nonweight-bearing relative to the control group regardless of CKD-EPI equation pairs compared ( < .001). In the patient subset with imaging and/or proteinuria evidence of renal dysfunction, the nonweight-bearing population again had different estimated glomerular filtration rate when calculated using CKD-EPI, CKD-EPI, and CKD-EPI (001). Fifty-eight percent of nonweight-bearing individuals with evidence of renal dysfunction on imaging or urinalysis were reclassified into a lower estimated glomerular filtration rate category when using estimated glomerular filtration rate relative to estimated glomerular filtration rate.
Estimated glomerular filtration rate equations containing serum creatinine, cystatin C, or both, validated in mostly ambulatory populations, are not equivalently accurate in estimating kidney function in nonweight-bearing individuals. Comparison of these equations against gold standard glomerular filtration rate measurement is needed to determine which most closely approximates true glomerular filtration rate.
患有神经肌肉疾病和神经源性下尿路功能障碍的个体通常不负重,且瘦肌肉质量低于一般人群。我们试图比较在不负重个体和相匹配的能行走的对照组中,包含肌酐、胱抑素C或两者的估算肾小球滤过率方程。
回顾了血清肌酐(Cr)和胱抑素C(Cys)记录以及诊断与不负重状态相符的个体,以及相匹配的能行走的对照组。使用2021年CKD-EPI(慢性肾脏病流行病学协作组)种族无关方程来计算估算肾小球滤过率。在总体队列以及有影像学和/或尿液分析证据表明存在肾功能不全的患者亚组中,按方程比较肾功能。
不负重人群(n = 102)和对照组人群(n = 204)的人口统计学特征相似。在不负重人群中,使用CKD-EPI、CKD-EPI和CKD-EPI计算时,估算肾小球滤过率有所不同(分别为107、93、80 mL/min/1.73 m²,P <.001)。无论比较哪一对CKD-EPI方程,不负重人群中估算肾小球滤过率的差异相对于对照组都更大(P <.001)。在有影像学和/或蛋白尿证据表明存在肾功能不全的患者亚组中,使用CKD-EPI、CKD-EPI和CKD-EPI计算时,不负重人群的估算肾小球滤过率再次存在差异(P <.001)。在影像学或尿液分析中有肾功能不全证据的不负重个体中,当使用相对于估算肾小球滤过率的估算肾小球滤过率时,58%的个体被重新分类到较低的估算肾小球滤过率类别。
在大多能行走的人群中验证的包含血清肌酐、胱抑素C或两者的估算肾小球滤过率方程,在估算不负重个体的肾功能时准确性并不相同。需要将这些方程与金标准肾小球滤过率测量值进行比较,以确定哪个最接近真实的肾小球滤过率。